NCI Lung Cancer Spiral CT Trial Expansion Under Review By Scientific Board
This article was originally published in The Gray Sheet
Executive Summary
The expansion of a National Cancer Institute-sponsored randomized, controlled trial to evaluate spiral computed tomography's ability to reduce lung cancer mortality will be voted on by NCI's Board of Scientific Advisors before its November meeting.